ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma.
Qu T, Zhang W, Yan C, Ren D, Wang Y, Guo Y, Guo Q, Wang J, Liu L, Han L, Li L, Huang Q, Cao L, Ye Z, Zhang B, Zhao Q, Cao W.
Qu T, et al. Among authors: cao w, cao l.
J Transl Med. 2023 May 22;21(1):341. doi: 10.1186/s12967-023-04135-1.
J Transl Med. 2023.
PMID: 37217923
Free PMC article.